Bionexo
PrivateLast Round
Growth Equity
Oct 20, 2023
Est. Valuation
$200.2M
Total Funding Raised
$101.6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Bionexo is a health tech company that provides an integrated suite of cloud software and a B2B marketplace to help hospitals and healthcare providers source critical care products and manage supply chain processes.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Supply Chain, Pharma Supply Chain, Healthcare Analytics, E-commerce
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionexo Comparables
Compare Bionexo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GHX Europe | 78% | |
| Procurement Partners | 67% | |
| Huma Tecnologia | 66% | |
Bionexo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Oct 20, 2023 | ||||
| Growth Equity | Oct 15, 2021 | ||||
| VC Round | Dec 13, 2018 | ||||
| Private Equity | Mar 24, 2017 | ||||
| VC Round | Jul 17, 2012 |
Key People
Founding team and executive leadership
Bionexo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Growth Equity |
| Apus Capital | Growth Equity |
| Bain Capital, LP | Growth Equity |
| Insight Partners | VC Round |
| Prisma Capital | Growth Equity, Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 31% MoM.
- Jun 15, 2026
Grew 82% QoQ from 507 to 922 employees
Bionexo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bionexo's valuation, stock price, and market status.